Free Trial

Lyra Therapeutics (LYRA) News Today

Lyra Therapeutics logo
$0.14 -0.01 (-8.32%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.14 0.00 (-0.71%)
As of 03/28/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Lyra Therapeutics (LYRA) Gets a Hold from William Blair
Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c)
Lyra Therapeutics Pursues ENLIGHTEN 2 Trial for LYR-210
Lyra Therapeutics, Inc. (LYRA)
Where Lyra Therapeutics Stands With Analysts
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Cut to "Neutral" at HC Wainwright
HC Wainwright downgraded shares of Lyra Therapeutics from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $12.00 to $2.00 in a research report on Tuesday.
Lyra Therapeutics, Inc. stock logo
Q2 2024 EPS Estimates for Lyra Therapeutics, Inc. (NASDAQ:LYRA) Decreased by Analyst
Lyra Therapeutics, Inc. (NASDAQ:LYRA - Free Report) - Analysts at HC Wainwright reduced their Q2 2024 EPS estimates for Lyra Therapeutics in a research report issued to clients and investors on Wednesday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the company will post earnin
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics' (LYRA) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $12.00 price objective on shares of Lyra Therapeutics in a research report on Wednesday.
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00
Bank of America decreased their price target on shares of Lyra Therapeutics from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Monday.
Lyra Therapeutics, Inc. stock logo
Lyra Therapeutics (NASDAQ:LYRA) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $12.00 price objective on shares of Lyra Therapeutics in a research report on Friday.
Remove Ads
Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.

LYRA Media Mentions By Week

LYRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LYRA
News Sentiment

0.43

0.82

Average
Medical
News Sentiment

LYRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LYRA Articles
This Week

2

0

LYRA Articles
Average Week

Remove Ads
Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LYRA) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners